Unicycive Therapeutics, Inc. (UNCY) Misses Q1 EPS by 82c

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) reported Q1 EPS of ($0.97), $0.82 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $675 thousand.

For earnings history and earnings-related data on Unicycive Therapeutics, Inc. (UNCY) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• NVE Corporation names new CEO and expands board to seven members